Skip to main content
OpenTrials

Clinical trial condition

Cholestasis

Explore clinical trials studying Cholestasis. Study availability and eligibility vary by location and protocol.

174 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Cholestasis trial results

Active, Not Recruiting

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

NCT04526665

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The Institute for Liver Health Chandler, Arizona, United States
  • Keck Medical Center of USC Los Angeles, California, United States
  • Ruane Clinical Research Group Inc. Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 115 locations
View Trial Details
Active, Not Recruiting

A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

NCT06730061

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Nippon Medical School - Chiba Hokusoh Hospital Chiba, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Chugoku Rosai Hospital Hiroshima, Japan
  • Teine Keijinkai Hospital Hokkaido, Japan
View all 16 locations
View Trial Details
Active, Not Recruiting

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

NCT05035030

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +11 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • UCSF San Francisco, California, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Riley Hospital for Children at IU Health Indianapolis, Indiana, United States
View all 35 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

NCT06247735

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • UA Thomas D. Boyer Liver Institute Tucson, Arizona, United States
  • Southern California Research Center - Coronado Coronado, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Velocity Clinical Research Santa Ana, California, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis

NCT06427395

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Zydus US013 Los Angeles, California, United States
  • Zydus US011 Pasadena, California, United States
  • Zydus US043 Sacramento, California, United States
  • Zydus US022 Aurora, Colorado, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Patients With Primary Biliary Cholangitis

NCT07573514

Conditions
Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, +20 more
Locations
  • Fondazione Policlinico Universitaro A. Gemelli IRCSS,UOC Medicina Interna e Gastroenterologia,Largo A. Gemelli, Roma, Italy
View Trial Details
Active, Not Recruiting

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

NCT03301506

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Arkansas Diagnostic Center Little Rock, Arkansas, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • California Liver Research Institute Pasadena, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
View all 109 locations
View Trial Details

Related conditions